Patents by Inventor Jinhua Du

Jinhua Du has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11572372
    Abstract: Disclosed are a class of anti-HBV tetrahydroisoxazolo[4,3-c]pyridine compounds and pharmaceutically acceptable salts thereof or isomers thereof, the compounds being represented by the formula (I).
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: February 7, 2023
    Assignee: Medshine Discovery Inc.
    Inventors: Lifang Wu, Fei Sun, Jinhua Du, Charles Z. Ding, Shuhui Chen, Xiquan Zhang, Hongjiang Xu, Ling Yang
  • Patent number: 11244108
    Abstract: Embodiments of the present invention provide a translation method and apparatus, and relate to the field of machine translation. The method includes: obtaining a to-be-translated sentence, where the to-be-translated sentence is a sentence expressed in a first language; determining a first named entity set in the to-be-translated sentence, and an entity type of each first named entity in the first named entity set; determining, based on the first named entity set and the entity type of each first named entity, a second named entity set expressed in a second language; determining a source semantic template of the to-be-translated sentence, and obtaining a target semantic template corresponding to the source semantic template from a semantic template correspondence; and determining a target translation sentence based on the second named entity set and the target semantic template.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: February 8, 2022
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Zhaopeng Tu, Longyue Wang, Jinhua Du
  • Patent number: 11008331
    Abstract: 10-oxo-6,1-dihydrobenzo[e]pyrido[1,2-c][1,3]oxazine-9-carboxylic acid derivatives of formula (I) as hepatitis B surface antigen inhibitors or pharmaceutically acceptable salts thereof, and uses of a compound of formula (I) or pharmaceutically acceptable salts thereof and pharmaceutical compositions thereof in preparation of medicaments for treatment of viral hepatitis B.
    Type: Grant
    Filed: March 9, 2018
    Date of Patent: May 18, 2021
    Assignee: FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
    Inventors: Fei Sun, Jinhua Du, Yanbin Hu, Lili Zhou, Charles Z. Ding, Shuhhui Chen
  • Publication number: 20200377517
    Abstract: Disclosed are a class of anti-HBV tetrahydroisoxazolo[4,3-c]pyridine compounds and pharmaceutically acceptable salts thereof or isomers thereof, the compounds being represented by the formula (I).
    Type: Application
    Filed: November 16, 2018
    Publication date: December 3, 2020
    Inventors: Lifang WU, Fei SUN, Jinhua DU, Charles Z. DING, Shuhui CHEN, Xiquan ZHANG, Hongjiang XU, Ling YANG
  • Publication number: 20200039995
    Abstract: 10-oxo-6,1-dihydrobenzo[e]pyrido[1,2-c][1,3]oxazine-9-carboxylic acid derivatives of formula (I) as hepatitis B surface antigen inhibitors or pharmaceutically acceptable salts thereof, and uses of a compound of formula (I) or pharmaceutically acceptable salts thereof and pharmaceutical compositions thereof in preparation of medicaments for treatment of viral hepatitis B.
    Type: Application
    Filed: March 9, 2018
    Publication date: February 6, 2020
    Applicants: FUJIAN COSUNTER PHARMACEUTICAL CO., LTD., MEDSHINE DISCOVERY INC.
    Inventors: Fei SUN, Jinhua DU, Yanbin HU, Lili ZHOU, Charles Z. DING, Shuhhui CHEN
  • Publication number: 20190311038
    Abstract: Embodiments of the present invention provide a translation method and apparatus, and relate to the field of machine translation. The method includes: obtaining a to-be-translated sentence, where the to-be-translated sentence is a sentence expressed in a first language; determining a first named entity set in the to-be-translated sentence, and an entity type of each first named entity in the first named entity set; determining, based on the first named entity set and the entity type of each first named entity, a second named entity set expressed in a second language; determining a source semantic template of the to-be-translated sentence, and obtaining a target semantic template corresponding to the source semantic template from a semantic template correspondence; and determining a target translation sentence based on the second named entity set and the target semantic template.
    Type: Application
    Filed: June 25, 2019
    Publication date: October 10, 2019
    Inventors: Zhaopeng TU, Longyue WANG, Jinhua DU
  • Publication number: 20180148452
    Abstract: Disclosed are a novel pyrrolopyrimidine ring compound as a TLR7 agonist or a pharmaceutically acceptable salt thereof, used for preventing or treating allergic rhinitis and asthma. In particular, disclosed is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 29, 2015
    Publication date: May 31, 2018
    Applicant: MEDSHINE DISCOVERY INC.
    Inventors: Charles Z. DING, Fei SUN, Lifang WU, Jinhua DU, Yasuhiro KATSU, Guoping HU, Jian LI
  • Publication number: 20130054224
    Abstract: A method for enhancing source-language coverage during statistical machine translation. The method including receiving an input string in a source language for translation into a target language. Extracting a paraphrase representation of the input string from a data repository comprising a corpus. Generating a word lattice structure using a directed acyclic graph representation having a plurality of nodes with edges extending there between. The words of the input string and the extracted paraphrase representation each having a respective edge in the directed acyclic graph. Labelling each of the edges with a word and a probability, the probability weighing assigned to the edges associated with the words of the input string being higher than the probability assigned to paraphrases derived from the input string.
    Type: Application
    Filed: August 30, 2012
    Publication date: February 28, 2013
    Applicant: DUBLIN CITY UNIVERSITY
    Inventors: JIE JIANG, Jinhua Du, Andrew Way